Canada markets open in 3 hours 38 minutes

Replimune Group, Inc. (REPL)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
33.10-0.51 (-1.52%)
At close: 4:00PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2021-03-31
2020-03-31
2019-03-31
2018-03-31
Total Revenue
0
0
0
0
0
Operating Expenses
Research Development
56,754
56,754
38,761
22,173
13,516
Selling General and Administrative
23,201
23,201
17,437
8,773
5,713
Total Operating Expenses
79,955
79,955
56,198
30,946
19,229
Operating Income or Loss
-79,955
-79,955
-56,198
-30,946
-19,229
Interest Expense
3,060
3,060
1,919
-
-
Total Other Income/Expenses Net
2,145
2,145
5,492
-2,473
-761
Income Before Tax
-80,870
-80,870
-52,625
-30,834
-19,702
Income from Continuing Operations
-80,870
-80,870
-52,625
-30,834
-19,702
Net Income
-80,870
-80,870
-52,625
-30,834
-19,702
Net Income available to common shareholders
-80,870
-80,870
-52,625
-30,834
-19,702
Basic EPS
-
-
-1.54
-1.33
-0.87
Diluted EPS
-
-
-1.54
-1.33
-0.87
Basic Average Shares
-
-
34,262
23,198
21,507
Diluted Average Shares
-
-
34,262
23,198
21,507
EBITDA
-
-76,099
-50,173
-30,798
-19,120